Αποτελέσματα Αναζήτησης
Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.
28 Μαΐ 2021 · EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 12 to 15. The vaccine is already approved for use in adults and adolescents aged 16 and above.
24 Νοε 2021 · It examines the role of COVID-19 vaccines in children and adolescents in the global context of inequitable vaccine distribution and access across countries at a time when many countries have not yet achieved high vaccine coverage rates in the highest and high priority-use groups.
28 Ιουν 2021 · Although vaccinating children is essential to reach herd immunity and limit the severity of COVID-19, safety should be the paramount factor to be considered before COVID-19 vaccine can be rolled out in younger children.
19 Οκτ 2022 · In children from 6 months to 4 years of age, Comirnaty can be given as primary vaccination consisting of three doses (of 3 micrograms each); the first two doses are given three weeks apart, followed by a third dose given at least 8 weeks after the second dose.
10 Σεπ 2021 · FDA leadership outlines steps the FDA will take to ensure the safety and efficacy of COVID-19 vaccines for young children
20 Μαΐ 2022 · The Centers for Disease Control and Prevention (CDC) recommends Pfizer-BioNTech’s COVID-19 vaccine for children ages 5 to 11, offering millions of children—and their parents—a greater sense of normalcy.
